• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

STK-1受体基因在多种人类非造血肿瘤细胞系中表达——STK-1 mRNA表达的逆转录聚合酶链反应定向分析。初步报告。

STK-1 receptor gene is expressed in various human non-hematopoietic tumor cell lines--RT-PCR directed analysis of STK-1 mRNA expression. Preliminary report.

作者信息

Kuczyński W I, Ratajczak M Z

机构信息

Department of Immunology CSK WAM, Warsaw.

出版信息

Acta Haematol Pol. 1994;25(1):43-6.

PMID:8209613
Abstract

The aim of this study was to evaluate the presence of the mRNA for the hematopoietic STK-1 receptor in various human tumor cell lines using RT-PCR directed analysis of gene expression. We have found STK-1R mRNA to be expressed in non-hematopoietic malignant cells of ectodermal, endodermal and mesodermal origin confirms a hypothesis that STK-1R is similar to other receptors with intrinsic tyrosine kinase activity, is not for specific hematopoiesis and is also expressed in non-hematopoietic cells. The fact that STK-1R is detectable in different tumor cell lines should also inspire further studies to evaluate its role in the transformation and growth of malignant cells.

摘要

本研究的目的是通过逆转录聚合酶链反应(RT-PCR)对基因表达进行定向分析,评估造血STK-1受体的mRNA在各种人类肿瘤细胞系中的存在情况。我们发现STK-1R mRNA在外胚层、内胚层和中胚层来源的非造血恶性细胞中表达,这证实了一个假设,即STK-1R与其他具有内在酪氨酸激酶活性的受体相似,并非特异性参与造血过程,也在非造血细胞中表达。STK-1R在不同肿瘤细胞系中可被检测到这一事实,也应促使进一步研究以评估其在恶性细胞转化和生长中的作用。

相似文献

1
STK-1 receptor gene is expressed in various human non-hematopoietic tumor cell lines--RT-PCR directed analysis of STK-1 mRNA expression. Preliminary report.STK-1受体基因在多种人类非造血肿瘤细胞系中表达——STK-1 mRNA表达的逆转录聚合酶链反应定向分析。初步报告。
Acta Haematol Pol. 1994;25(1):43-6.
2
FLT3/FLK-2 (STK-1) Ligand does not stimulate human megakaryopoiesis in vitro.FLT3/FLK-2(STK-1)配体在体外不刺激人巨核细胞生成。
Stem Cells. 1996 Jan;14(1):146-50. doi: 10.1002/stem.140146.
3
[Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].[急性髓系白血病中生长因子受体Flt3的突变:通过Ras依赖和Ras非依赖机制使髓系细胞发生转化]
Dtsch Med Wochenschr. 2002 Oct 18;127(42):2195-200. doi: 10.1055/s-2002-34942.
4
STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells.STK-1是Flk-2/Flt-3的人类同源物,在CD34+人类骨髓细胞中选择性表达,并参与早期祖细胞/干细胞的增殖。
Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):459-63. doi: 10.1073/pnas.91.2.459.
5
cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain.NET(EPHT2)的cDNA克隆、分子特征及染色体定位,NET是一种在脑中优先表达的人EPH相关受体蛋白酪氨酸激酶基因。
Genomics. 1995 Sep 20;29(2):426-37. doi: 10.1006/geno.1995.9985.
6
17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.17β-雌二醇对培养的人正常乳腺细胞和乳腺癌细胞中蛋白酪氨酸磷酸酶γ基因表达的调控
Anticancer Res. 2000 Jan-Feb;20(1A):11-9.
7
erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.erbB家族受体在新分离的人乳腺癌细胞系中的表达及生长调控
Cancer Res. 1996 Feb 15;56(4):899-907.
8
Lack of rearranged Tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma.人胃癌细胞系、胃黏膜及癌组织中未检测到重排的Tpr-met mRNA表达。
Anticancer Res. 1996 Sep-Oct;16(5A):2881-4.
9
Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.肿瘤启动子在对转化敏感而非抗性的细胞中诱导高迁移率族HMG-Y蛋白表达。
Oncogene. 1998 Jul 2;16(26):3387-96. doi: 10.1038/sj.onc.1201888.
10
Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.KRAS2、2型肌醇1,4,5-三磷酸受体基因以及一种新的人类基因KRAG在肿瘤中的共扩增。
Genomics. 1996 Jul 1;35(1):207-14. doi: 10.1006/geno.1996.0340.